Evotec获得施贵宝500万美元的里程碑付款

投资观察
Nov 20, 2025

11月12日(路透社)- Evotec SE:*EVOTEC SE - 在与施贵宝的战略合作伙伴关系中,因IND申请获得批准,收到里程碑付款。*EVOTEC SE - 此药物候选剂是在该合作中开发的,预计将在2026年开始进行I期临床试验。*EVOTEC SE - IND申请的FDA批准触发了对EVOTEC的500万美元里程碑付款。*进一步公司的相关信息:EVTG.DE*

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10